NovaBridge Biosciences (NBP) Insider Trading
Over the last 3 months, NBP insiders made 1 open-market buy and 3 sales, a net purchase of $515K (SEC Form 4).
Insider Activity
Sentiment
90/100
Buys (3m)
1
Sells (3m)
3
Net (3m)
$515.3K
Insiders buying
Insider trades by month Buys Sells
Apr
May
Jun
Context3-month price -11.6%
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 24, 2026 | Cao Sean Wuxiongdirector, officer: Chief Bus. Development Officer | Grant | 181,280 | — |
| Jun 24, 2026 | Cao Sean Wuxiongdirector, officer: Chief Bus. Development Officer | Grant | 181,290 | $1.53 |
| Jun 22, 2026 | Dennis Phillip Andrewofficer: Chief Medical Officer | Option | 23,695 | — |
| Jun 22, 2026 | Dennis Phillip Andrewofficer: Chief Medical Officer | Sell | 8,494 | $0.66 |
| Jun 22, 2026 | Dennis Phillip Andrewofficer: Chief Medical Officer | Option | 10,302 | — |
| Jun 2, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Option | 4,079 | — |
| Jun 2, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Option | 9,382 | — |
| Jun 2, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Sell | 3,494 | $3.94 |
| May 18, 2026 | Cao Sean Wuxiongdirector, officer: See Remarks | Sell | 21,399 | $1.99 |
| Apr 28, 2026 | Hagler Mark Arnoldofficer: See Remarks | Buy | 230,000 | $2.51 |
Source: NBP SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.